Bionano Genomics to Present at the 32nd Annual Oppenheimer Healthcare Conference

Rhea-AI Summary

Bionano Genomics (BNGO) announced that its management will present virtually at the 32nd Annual Oppenheimer Healthcare Conference. CEO Erik Holmlin is scheduled to deliver a corporate overview on March 15, 2022, at 5:40 am PT/8:40 am ET. The presentation will be accessible on Bionano’s Investors section on their website. The company specializes in optical genome mapping and offers software solutions for genomic data visualization and interpretation, aiming to revolutionize genome analysis in research and diagnostics.

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr^® system and provider of N_xClinical™, a leading software solution for visualization, interpretation, and reporting of genomic data, announced today that company management will present virtually at the 32^nd Annual Oppenheimer Healthcare Conference. Erik Holmlin, PhD, Bionano’s president and chief executive officer, is scheduled to present a corporate overview on Tuesday, March 15th, 2022 at 5:40 am PT/8:40 am ET. 

The presentation will be available to view on the Events page in the Investors section of Bionano’s website.

About Bionano Genomics

Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit bionanogenomics.com, lineagen.com or biodiscovery.com.

CONTACTS

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com

Investor Relations:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com

Media Relations:
Michael Sullivan
Seismic
+1 (503) 799-7520
michael@teamseismic.com

 

FAQ

When is Bionano Genomics presenting at the Oppenheimer Healthcare Conference?

Bionano Genomics will present on March 15, 2022, at 5:40 am PT/8:40 am ET.

Who is presenting for Bionano Genomics at the conference?

Erik Holmlin, CEO of Bionano Genomics, will present at the conference.

Where can I watch Bionano Genomics' presentation?

The presentation can be viewed on the Events page in the Investors section of Bionano’s website.

What is Bionano Genomics known for?

Bionano Genomics is known for its optical genome mapping solutions and genomic data analysis software.

What date is the 32nd Annual Oppenheimer Healthcare Conference?

The conference is on March 15, 2022.